Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex
about
A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to RhoTRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptorBiochemical and molecular characterization of two phosphatidic acid-selective phospholipase A1s, mPA-PLA1alpha and mPA-PLA1betaPurification and characterization of a lysophosphatidic acid-specific phosphataseSphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands.NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activationEdg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturationA single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acidIdentification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid productionRecent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivoSecret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative researchG-Protein-Coupled Lysophosphatidic Acid Receptors and Their Regulation of AKT SignalingLysophospholipids and their receptors in the central nervous systemLipid phosphate phosphatase (LPP3) and vascular developmentFingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapyRegulation of T cell motility in vitro and in vivo by LPA and LPA2Lysophospholipid receptors LPA1–3 are not required for the inhibitory effects of LPA on mouse retinal growth conesMembrane-derived phospholipids control synaptic neurotransmission and plasticityStructural basis of transport of lysophospholipids by human serum albuminLysophospholipid receptors in drug discovery.Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5Nrg-1 belongs to the endothelial differentiation gene family of G protein-coupled sphingosine-1-phosphate receptorsA novel phosphatidic acid-selective phospholipase A1 that produces lysophosphatidic acidImmunohistological localization of the myelinating cell-specific receptor LP(A1)Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptorsSphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218Assessment of agonism at G-protein coupled receptors by phosphatidic acid and lysophosphatidic acid in human embryonic kidney 293 cellsA novel function of sphingosine-1-phosphate to activate a non-selective cation channel in human endothelial cellsExpression and function of lysophosphatidic acid receptors in cultured rodent microglial cellsA rat G protein-coupled receptor selectively expressed in myelin-forming cellsMolecular cloning and expression regulation of PRG-3, a new member of the plasticity-related gene familyReceptor-mediated vascular smooth muscle migration induced by LPA involves p38 mitogen-activated protein kinase pathway activationEdg-2 in myelin-forming cells: isoforms, genomic mapping, and exclusion in Charcot-Marie-Tooth diseaseLPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activationLysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA speciesPharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.Role of LPA4/p2y9/GPR23 in negative regulation of cell motility
P2860
Q22008793-4370C14E-F06B-480A-B626-41712B37D4BEQ24302424-397A47D4-A328-4BED-9E40-299892CD7A56Q24321678-51D15939-AB6F-4FC7-AD06-D3046B5C63E4Q24531330-A2BA7E11-85D3-42B4-A38B-6A54037A8A7CQ24532043-593125E1-F927-4E22-B2A7-AA9592323A7CQ24536334-1C4C28C4-FAB5-40A1-A40A-3196EBA6150EQ24563311-0B74CAA9-E705-4D22-B3B0-4BD4C1450F3AQ24629370-0A113208-2F75-4ADD-ABFD-69B2F7EC7C55Q24654174-697665E0-A390-4AE3-8BE7-EDB9EE0BCE15Q24658261-AF58CF12-B630-44F6-8310-6D9278891F97Q24673806-3D6596F3-DFCD-475C-9EF2-F38668D18242Q26741062-13EE16AC-A23A-45DB-A708-6E05E631756FQ26751362-D2C63362-E35B-4376-B0CC-0EA881CAE279Q26767279-5ED61790-A3B9-4FE6-8A81-0EA3FF968B20Q26859168-AEE48CD1-7946-4E84-8ECA-FCEEFB52A544Q27002640-39766318-C6AF-4E5E-B3DE-9E076EE7F3CBQ27011473-95EF38FA-6700-4BB7-B282-DC5317AD3ED8Q27320538-57893D98-22F4-44C2-92DE-92DF858E02CAQ27337671-2379EFA3-E0DC-4AEE-A5B7-A69987B14F0BQ27347783-133074EB-2803-4E2B-97CA-51B183900424Q27656406-2B687DF8-769B-4A54-B1F4-0E381E75BBD2Q27692680-4BC64B52-2E8B-4C2D-886E-99665459C576Q28138229-1C55362F-7782-4D6A-9BA0-0771563D7B5CQ28143305-EBE44D38-3027-4498-AECC-F9C3D33ACF20Q28204400-EF2EEDB7-85BA-4F5A-B9BC-ED28DEE81F40Q28214471-3A6EC430-9826-4EE2-A1CC-E7AEFC6DF7C5Q28215028-3667A42F-8C49-4CDF-9E71-CAA8AD95A2D4Q28297208-2CEC9DC3-F099-46C3-B2B7-6004C1063386Q28346692-0D348385-4AEB-4037-886B-87931E8812B6Q28365690-C6361611-C65B-4C72-821F-FE8DCBF038D4Q28567087-C3596A99-C2BD-4A80-BDCE-5DD16E0147B8Q28569876-4C2DCAED-682C-45F9-AFB6-87DE80B448EBQ28572051-4B91BB52-12E4-4C2C-846C-FF9A00599C6AQ28582283-015FFD3E-0837-4B0C-BEE0-D32C38F2A550Q28583631-88AC2318-0985-4212-9ED7-E28307182083Q28589775-7414AAC6-C0DA-41FF-BDAC-8ACDCAFD84DEQ30051813-44618224-5BBB-4AD9-A043-C9DA083B09E6Q30410634-B3DC019C-1E62-4EE5-BCE1-9556A05F236FQ30429523-BE743CBA-2531-4E25-A448-77DB27A387ADQ30440331-C15332D1-5374-44DC-AAEF-59B8296E6D5B
P2860
Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
name
Ventricular zone gene-1 (vzg-1 ...... the developing cerebral cortex
@ast
Ventricular zone gene-1 (vzg-1 ...... the developing cerebral cortex
@en
Ventricular zone gene-1 (vzg-1 ...... the developing cerebral cortex
@en-gb
Ventricular zone gene-1 (vzg-1 ...... the developing cerebral cortex
@nl
type
label
Ventricular zone gene-1 (vzg-1 ...... the developing cerebral cortex
@ast
Ventricular zone gene-1 (vzg-1 ...... the developing cerebral cortex
@en
Ventricular zone gene-1 (vzg-1 ...... the developing cerebral cortex
@en-gb
Ventricular zone gene-1 (vzg-1 ...... the developing cerebral cortex
@nl
prefLabel
Ventricular zone gene-1 (vzg-1 ...... the developing cerebral cortex
@ast
Ventricular zone gene-1 (vzg-1 ...... the developing cerebral cortex
@en
Ventricular zone gene-1 (vzg-1 ...... the developing cerebral cortex
@en-gb
Ventricular zone gene-1 (vzg-1 ...... the developing cerebral cortex
@nl
P2093
P2860
P3181
P356
P1476
Ventricular zone gene-1 (vzg-1 ...... the developing cerebral cortex
@en
P2093
P2860
P304
P3181
P356
10.1083/JCB.135.4.1071
P407
P577
1996-11-01T00:00:00Z